| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 Oct 24 | UPB Upstream Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 17,096 | 290.63 k | 17,096 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 83,857 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 160,452 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 320,742 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 284,023 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0 | 215,749 | 0.00 | 0 |
| 19 Jan 24 | CERE Cerevel Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 284,023 | 0.00 | 284,023 |
| 19 Dec 23 | CERE Cerevel Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 160,452 | 0.00 | 160,452 |
| 19 Dec 23 | CERE Cerevel Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 160,452 | 0.00 | 0 |
